Terms: = Thyroid cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
6 results:
1. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
[TBL] [Abstract] [Full Text] [Related]
2. [Mining and discovery for active components of "Coptidis Rhizome-Magnoliae Officinalis Cortex" based on network pharmacology].
Wu HN; Yu GH; Zhao FZ; Jia XB; Feng L; Shi XH
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):803-810. PubMed ID: 30989895
[TBL] [Abstract] [Full Text] [Related]
3. Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.
Swierniak M; Pfeifer A; Stokowy T; Rusinek D; Chekan M; Lange D; Krajewska J; Oczko-Wojciechowska M; Czarniecka A; Jarzab M; Jarzab B; Wojtas B
Mol Cell Endocrinol; 2016 Sep; 433():130-7. PubMed ID: 27283500
[TBL] [Abstract] [Full Text] [Related]
4. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract] [Full Text] [Related]
5. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
Szapary D; Huang Y; Simons SS
Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
[TBL] [Abstract] [Full Text] [Related]
6. Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and tif2.
Kim HJ; Lee SK; Na SY; Choi HS; Lee JW
Mol Endocrinol; 1998 Jul; 12(7):1038-47. PubMed ID: 9658407
[TBL] [Abstract] [Full Text] [Related]
